HIGHLIGHTS Amplia’s lead drug narmafotinib enhances the activity of kRAS inhibitors in multiple preclinical cancer models presented at US conferenceData showing narmafotinib activity in preclinical ...

Allarity closes $20 mn financing to accelerate the advance of stenoparib toward US FDA approval and commercialization: Tarpon Springs, Florida Monday, March 9, 2026, 15:00 Hrs [IS ...

Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper ...

Obesity is now linked to at least 13 types of cancer, making it one of the most preventable cancer risk factors in the United ...

Initial MGC028 (ADAM9 ADC) Phase 1 results in second half of 2026; Lorigerlimab Phase 2 LINNET study update in mid-2026; IN ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Korean Ministry of Intellectual ...

In Britain young people are now considered one of the most at-risk groups of bowel cancer , but experts say diet, lifestyle, ...

A breakthrough in the fight against pancreatic cancer was unveiled this week, after experts discovered a drug combination that may be able to defeat the disease. The treatment, which involves three ...

A cancer dietitian has shared 10 simple diet and lifestyle changes you can make to reduce your risk of cancer, from eating ...

VA marijuana resentencing; OR & CO medical cannabis in healthcare facilities; UT psychedelics; MD firefighter marijuana protections Subscribe to receive Marijuana Moment’s newsletter in your inbox ...

ALS News Today joins the ALS Network’s ASK ME ALS webinar series as presenting sponsor, offering expert discussions on ALS ...

A clinical study examining 243 robotic-assisted myomectomy procedures performed by Dr Rooma Sinha has reported pregnancy and birth outcomes following treatment for uterine fibroids. The study included ...